A phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma (Q42599978)
Jump to navigation
Jump to search
scientific article published on 5 October 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma |
scientific article published on 5 October 2006 |
Statements
1 reference
A phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma (English)
1 reference
Guy Arthur Van Hazel
1 reference
Michael Millward
1 reference
James Marshall Trotter
1 reference
Rada Kusic
1 reference
Revati Shreeniwas
1 reference
Adele Morganti
1 reference
Andrea Ballmer
1 reference
Eleonor Segal
1 reference
Oliver Nayler
1 reference
Martine Clozel
1 reference
5 October 2006
1 reference
1 reference
25
1 reference
3
1 reference
247-252
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference